Self-injection or administered Dose Range 0.25 mg - 2.4 mg Targets GLP-1 Agonist Most Common Side Effects Nausea, vomiting, diarrhea, constipation, abdominal pain Weight Loss Efficacy 15% average body weight lost Indications BMI 30 or greater BMI 27+ with one or more weight related health issues Type 2 Diabetes Out-of-Pocket Cost (Branded) $900 - $1,300 USD According to GoodRx Trizepatide Brand Name Mounjaro, Zepbound FDA Approved Yes Delivery Once weekly injection, subcutaneously
Oral BPC-157 still has systemic absorption, but the local GI concentration is higher than what subcutaneous injection provides
Patients should not discontinue or alter thyroid hormone replacement when using tirzepatide, and close endocrinologic supervision remains essential
It reduces appetite by increasing levels of N-lactoyl-phenylalanine (lac-phe), a molecule known for its "anti-hunger" effects, which is also produced during intense physical activity